Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Yalcin, ŞUAYİB; Oksuzoglu, B; Tekuzman, G; Engin, H; Celik, İSMAİL; Turker, A; Barista, İBRAHİM; Gullu, İBRAHİM; Guler, N; Altundag, K; Ozisik, Y; Kars, A

doi:10.1093/jjco/hyg111

Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Atıf İçin Kopyala

Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., ...Daha Fazla

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.33, sa.11, ss.580-583, 2003 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 33 Sayı: 11
Basım Tarihi: 2003
Doi Numarası: 10.1093/jjco/hyg111
Dergi Adı: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.580-583
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: In this study, we evaluated the efficacy and tolerability of biweekly irinotecan (CPT-11) plus 5-fluorouracil (5-FU) and folinic acid (FA) regimen (IFL) in patients with advanced stage colorectal cancer.